Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 USD | 0.00% | 0.00% | -11.35% |
Valuation
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Capitalization 1 | 252.1 | 107.2 |
Enterprise Value (EV) 1 | 251.7 | 111.2 |
P/E ratio | 97.2 x | -267 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | - | - |
EV / FCF | -463,642,760 x | 3,224,139 x |
FCF Yield | -0% | 0% |
Price to Book | -19.4 x | -4.55 x |
Nbr of stocks (in thousands) | 25,156 | 10,064 |
Reference price 2 | 10.02 | 10.65 |
Announcement Date | 3/31/22 | 8/24/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | - | - |
EBIT 1 | -0.0625 | -4.106 | -2.371 |
Operating Margin | - | - | - |
Earnings before Tax (EBT) 1 | -0.062 | 2.49 | -0.4255 |
Net income 1 | -0.062 | 2.49 | -0.4868 |
Net margin | - | - | - |
EPS | - | 0.1031 | -0.0398 |
Free Cash Flow | - | -0.5428 | 34.5 |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 4/9/21 | 3/31/22 | 8/24/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | - | - | 4.06 |
Net Cash position 1 | 2.87 | 0.4 | - |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | -0.54 | 34.5 |
ROE (net income / shareholders' equity) | - | -17.4% | 3.35% |
ROA (Net income/ Total Assets) | - | -1.25% | -1.15% |
Assets 1 | - | -199.3 | 42.31 |
Book Value Per Share 2 | 0.2000 | -0.5200 | -2.340 |
Cash Flow per Share 2 | 0.1200 | 0.0200 | 0 |
Capex | - | - | - |
Capex / Sales | - | - | - |
Announcement Date | 4/9/21 | 3/31/22 | 8/24/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-11.35% | 66.49M | |
+154.80% | 6.04B | |
+2.19% | 982M | |
+41.91% | 872M | |
+26.41% | 853M | |
+2.11% | 664M | |
+5.03% | 620M | |
-.--% | 600M | |
+7.78% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- VHAQ Stock
- Financials Viveon Health Acquisition Corp.